Company / Shareholders' Equity
Cocrystal Pharma, Inc. Shareholders' Equity History
FY2012-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$77.5M
FY2021
5-year range
-$5.0M / $77.5M
FY2017-FY2021
Trend
+201.7%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity changed +202% YoY in FY2021, a notable deviation from the 3-year average annual change of +525%.
Based on SEC 10-K filings.
$78M in FY2021.
Improved from $67M to $78M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, shareholders' equity increased 201.7% year-over-year.
Company context
Key Data Points
- Altman Z-Score 14.87 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $77.5M | +201.7% |
| FY2020 | $25.7M | -61.6% |
| FY2019 | $66.9M | +1435.6% |
| FY2012 | -$5.0M | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026